• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to project page

2021 Fiscal Year Final Research Report

Identification of pathogenic alpha-synuclein species that exhibit prion-like properties in Lewy body dementia, and basic research for drug development

Research Project

  • PDF
Project/Area Number 19K07858
Research Category

Grant-in-Aid for Scientific Research (C)

Allocation TypeMulti-year Fund
Section一般
Review Section Basic Section 51030:Pathophysiologic neuroscience-related
Research InstitutionFukuoka University

Principal Investigator

Sano Kazunori  福岡大学, 薬学部, 准教授 (50534343)

Project Period (FY) 2019-04-01 – 2022-03-31
Keywordsレビー小体型認知症 / α-シヌクレイン / プリオン様伝播 / S129リン酸化 / Y136リン酸化 / Casein kinaseⅡ
Outline of Final Research Achievements

We found that α-synuclein (αSyn) aggregates are predominantly phosphorylated at Y136 in the Lewy body dementia (LBD) brain. Aggregate formation with S129 and Y136 phosphorylation of recombinant αSyn (r-αSyn) were induced by Casein kinase 2 (CK2) but abolished by replacement of S129 with alanine (S129A) in vitro. Mutation of Y136 to alanine (Y136A) promoted aggregate formation and S129 phosphorylation of r-αSyn by CK2 in vitro. Introduction of Y136A r-αSyn oligomers into cultured cells exhibited increased levels of aggregates with S129 phosphorylation compared to wild-type r-αSyn oligomers. In addition, aggregate formation with S129 phosphorylation induced by introduction of wild-type r-αSyn oligomers was significantly attenuated by CK2 inhibition, which resulted in an unexpected increase in Y136 phosphorylation in cultured cells. Our findings suggest the involvement of CK2-related αSyn Y136 phosphorylation in the pathogenesis of LBD and its potential as a therapeutic target.

Free Research Field

神経内科学

Academic Significance and Societal Importance of the Research Achievements

2002年にレビー小体型認知症(LBD)脳における異常αSynのS129リン酸化が同定されたものの、そのリン酸化機序や役割は不明確なままである。このことはS129リン酸化に影響する因子の存在を示唆しており、本研究ではその因子としてY136リン酸化を世界で初めて同定した。
S129リン酸化が見られる疾患にはパーキンソン病(PD)もあり、LBDやPDに対する現在の治療法は対症療法のみである。根治療法が確立されない要因として、異常αSyn本体が未解明なことが挙げられ、本研究成果で見出した異常αSynのY136リン酸化やオリゴマー構造は、LBD、PDの病態解明、根治療法開発への基盤になりうると考える。

URL: 

Published: 2023-01-30  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi